Mary Fenton
Director/Board Member bij Connecticut Business & Industry Association
Vermogen: 155 835 $ op 31-03-2024
Profiel
Mary Kay Fenton is currently the Director at Connecticut Business & Industry Association.
She previously held positions as an Independent Director at Oncorus, Inc. from 2019 to 2023, Vice President-Strategic Operations at Vertex Pharmaceuticals, Inc. from 2019 to 2021, Senior Manager-Technology Industry Group at PricewaterhouseCoopers LLP from 1991 to 2000, CFO, Principal Accounting Officer & Executive VP at Achillion Pharmaceuticals, Inc. from 2000 to 2018, Chief Operating & Financial Officer at Semma Therapeutics, Inc. in 2019, and Chief Financial Officer at Talaris Therapeutics, Inc. from 2021 to 2023.
Ms. Fenton obtained an undergraduate degree from the College of the Holy Cross (Massachusetts) and an MBA from the University of Connecticut School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0.03% | 03-07-2023 | 6 805 ( 0.03% ) | 155 835 $ | 31-03-2024 |
ONCORUS, INC.
-.--% | 31-03-2023 | 0 ( -.--% ) | - $ | 31-12-2023 |
Actieve functies van Mary Fenton
| Bedrijven | Functie | Begin |
|---|---|---|
Connecticut Business & Industry Association
 Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Connecticut Business & Industry Association is a non-profit organization that provides commercial support services. The private company is based in Hartford, CT. Joseph F. Brennan has been the CEO of the company since 1988. | Director/Board Member | 06-12-2018 |
Eerdere bekende functies van Mary Fenton
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCORUS, INC. | Director/Board Member | 27-07-2023 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-02-2021 |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01-10-2019 |
| ACHILLION PHARMACEUTICALS, INC. | Director of Finance/CFO | 28-12-2018 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01-10-2000 |
Opleiding van Mary Fenton
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| University of Connecticut School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| ONCORUS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Connecticut Business & Industry Association
Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Connecticut Business & Industry Association is a non-profit organization that provides commercial support services. The private company is based in Hartford, CT. Joseph F. Brennan has been the CEO of the company since 1988. | Commercial Services |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Health Technology |
